MedTrace Logo

AG & IM in CA Stomach Protocol

NCT04184960 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-09-07

No results posted yet for this study

Summary

This is a multi-center prospective case control study aiming to compare different methods of risk stratification models in predicting the risk of gastric cancer development.

Conditions

Interventions

DIAGNOSTIC_TEST

Gastroscopy and gastric biopsies

Gastroscopy would be performed to assess the degree of atrophic gastritis and intestinal metaplasia. In addition, four random biopsies would be taken in the stomach for histological assessment of AG and IM

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Hon Chi Yip · Chinese University of Hong Kong

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-05
Primary Completion
2024-01-31
Completion
2024-03-31

Countries

  • Hong Kong
  • Japan
  • Singapore
  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04184960 on ClinicalTrials.gov